As part of that programme, CoronaVac, being tested in final-stage large-scale trials in Brazil, Indonesia and Turkey, has already been given to about 90% of the company's employees and their families.
from The Hindu - Home https://ift.tt/2EbXCEA
https://ift.tt/2IyLjhI
from The Hindu - Home https://ift.tt/2EbXCEA
https://ift.tt/2IyLjhI
Comments
Post a Comment